Overview

Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Status:
RECRUITING
Trial end date:
2032-03-01
Target enrollment:
Participant gender:
Summary
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Phase:
PHASE2
Details
Lead Sponsor:
Glaukos Corporation